We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.84%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$1.13B
AUM Growth
+$319M
Cap. Flow
+$340M
Cap. Flow %
30.14%
Top 10 Hldgs %
55.39%
Holding
5,820
New
1,131
Increased
1,662
Reduced
1,677
Closed
1,186

Sector Composition

Rank Sector Weight
1 Financials 2.49%
2 Industrials 2.24%
3 Healthcare 2.07%
4 Consumer Discretionary 2.05%
5 Energy 1.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRI icon
1326
Herc Holdings
HRI
$5.48B
$52K ﹤0.01%
962
-4,713
-83% -$291K
LPLA icon
1327
LPL Financial
LPLA
$28.4B
$52K ﹤0.01%
1,110
-3,750
-77% -$162K
MGPI icon
1328
MGP Ingredients
MGPI
$370M
$52K ﹤0.01%
3,069
+2,457
+401% +$39.2K
PBI icon
1329
Pitney Bowes
PBI
$2.48B
$52K ﹤0.01%
2,502
+1,074
+75% +$24.2K
SCM icon
1330
Stellus Capital Investment Corp
SCM
$225M
$52K ﹤0.01%
+4,602
New +$56K
SPCB icon
1331
SuperCom
SPCB
$68.1M
$52K ﹤0.01%
21
+1
+5% +$2.36K
TISI icon
1332
Team
TISI
$77.7M
$52K ﹤0.01%
130
+63
+94% +$25.2K
MDC
1333
DELISTED
M.D.C. Holdings, Inc.
MDC
$52K ﹤0.01%
2,399
+298
+14% +$6.1K
PTLA
1334
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$52K ﹤0.01%
1,140
-1,640
-59% -$66K
ESIO
1335
DELISTED
Electro Scientific Industries
ESIO
$52K ﹤0.01%
+9,969
New +$56.7K
POT
1336
DELISTED
Potash Corp Of Saskatchewan
POT
$52K ﹤0.01%
1,351
-49,092
-97% -$1.57M
PGI
1337
DELISTED
PREMIERE GLOBAL SERVICES, INC.
PGI
$52K ﹤0.01%
+5,100
New +$51.4K
JSD
1338
DELISTED
NUVEEN SHORT DURATION CREDIT OPPORTUNITIES FUND
JSD
$52K ﹤0.01%
+3,173
New +$54.5K
AGD
1339
abrdn Global Dynamic Dividend Fund
AGD
$315M
$51K ﹤0.01%
+5,104
New +$52.8K
CMC icon
1340
Commercial Metals
CMC
$7.77B
$51K ﹤0.01%
+3,201
New +$52.3K
CORT icon
1341
Corcept Therapeutics
CORT
$12.2B
$51K ﹤0.01%
8,389
+4,962
+145% +$30.4K
KUST
1342
Kustom Entertainment Inc
KUST
$1M
0
DOC icon
1343
Healthpeak Properties
DOC
$14.9B
$51K ﹤0.01%
1,526
-723
-32% -$26.3K
EIDO icon
1344
iShares MSCI Indonesia ETF
EIDO
$494M
$51K ﹤0.01%
2,199
+1,906
+651% +$48.9K
HOLX
1345
DELISTED
Hologic
HOLX
$51K ﹤0.01%
1,341
+140
+12% +$4.9K
NGVC icon
1346
Vitamin Cottage Natural Grocers
NGVC
$765M
$51K ﹤0.01%
2,070
-665
-24% -$17K
PB icon
1347
Prosperity Bancshares
PB
$9.02B
$51K ﹤0.01%
875
-4,301
-83% -$234K
PHM icon
1348
Pultegroup
PHM
$24.6B
$51K ﹤0.01%
2,537
+2,037
+407% +$41.3K
TG icon
1349
Tredegar Corp
TG
$267M
$51K ﹤0.01%
+2,314
New +$48.5K
VTOL icon
1350
Bristow Group
VTOL
$1.35B
$51K ﹤0.01%
1,250
+400
+47% +$17.2K

Similar funds

Tower Research Capital (TRC)'s Q2 2015 Portfolio in Review

As of Q2 2015, Tower Research Capital (TRC) held 5,820 positions worth $1.13B, up 39% from $809M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Tower Research Capital (TRC) deployed $340M of net new capital in Q2 2015, opening 1,131 new positions and adding to 1,662 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 126,017 shares worth $23.8M.

By sector, the portfolio is most concentrated in Financials at 2.5% of assets, down from 4.6% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $42.4M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2015 buy was Vanguard S&P 500 ETF: 126,017 shares worth $23.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $337M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2015 reduction was Invesco QQQ Trust, cutting an estimated $42.4M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 ETF in Q2 2015, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 55% of its $1.13B portfolio in Q2 2015.
  • Tower Research Capital (TRC) opened 1,131 new positions and closed 1,186 in Q2 2015.
  • Tower Research Capital (TRC)'s portfolio value rose 39% quarter-over-quarter to $1.13B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2015, filed 30 Jul 2015.